S&P 500   3,960.26 (-0.08%)
DOW   33,692.98 (-0.26%)
QQQ   284.31 (+0.16%)
AAPL   144.22 (+1.10%)
MSFT   246.74 (-0.27%)
META   116.72 (+1.21%)
GOOGL   93.52 (-0.20%)
AMZN   89.62 (-0.81%)
TSLA   181.16 (+4.45%)
NVDA   173.36 (+0.97%)
NIO   12.86 (-4.10%)
BABA   92.37 (-1.91%)
AMD   69.60 (-1.23%)
T   19.17 (+0.26%)
MU   55.54 (+0.62%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.19 (-1.72%)
DIS   94.09 (+1.66%)
AMC   5.81 (-4.28%)
PYPL   74.21 (-0.01%)
PFE   51.88 (+0.19%)
NFLX   324.33 (+4.53%)
S&P 500   3,960.26 (-0.08%)
DOW   33,692.98 (-0.26%)
QQQ   284.31 (+0.16%)
AAPL   144.22 (+1.10%)
MSFT   246.74 (-0.27%)
META   116.72 (+1.21%)
GOOGL   93.52 (-0.20%)
AMZN   89.62 (-0.81%)
TSLA   181.16 (+4.45%)
NVDA   173.36 (+0.97%)
NIO   12.86 (-4.10%)
BABA   92.37 (-1.91%)
AMD   69.60 (-1.23%)
T   19.17 (+0.26%)
MU   55.54 (+0.62%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.19 (-1.72%)
DIS   94.09 (+1.66%)
AMC   5.81 (-4.28%)
PYPL   74.21 (-0.01%)
PFE   51.88 (+0.19%)
NFLX   324.33 (+4.53%)
S&P 500   3,960.26 (-0.08%)
DOW   33,692.98 (-0.26%)
QQQ   284.31 (+0.16%)
AAPL   144.22 (+1.10%)
MSFT   246.74 (-0.27%)
META   116.72 (+1.21%)
GOOGL   93.52 (-0.20%)
AMZN   89.62 (-0.81%)
TSLA   181.16 (+4.45%)
NVDA   173.36 (+0.97%)
NIO   12.86 (-4.10%)
BABA   92.37 (-1.91%)
AMD   69.60 (-1.23%)
T   19.17 (+0.26%)
MU   55.54 (+0.62%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.19 (-1.72%)
DIS   94.09 (+1.66%)
AMC   5.81 (-4.28%)
PYPL   74.21 (-0.01%)
PFE   51.88 (+0.19%)
NFLX   324.33 (+4.53%)
S&P 500   3,960.26 (-0.08%)
DOW   33,692.98 (-0.26%)
QQQ   284.31 (+0.16%)
AAPL   144.22 (+1.10%)
MSFT   246.74 (-0.27%)
META   116.72 (+1.21%)
GOOGL   93.52 (-0.20%)
AMZN   89.62 (-0.81%)
TSLA   181.16 (+4.45%)
NVDA   173.36 (+0.97%)
NIO   12.86 (-4.10%)
BABA   92.37 (-1.91%)
AMD   69.60 (-1.23%)
T   19.17 (+0.26%)
MU   55.54 (+0.62%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.19 (-1.72%)
DIS   94.09 (+1.66%)
AMC   5.81 (-4.28%)
PYPL   74.21 (-0.01%)
PFE   51.88 (+0.19%)
NFLX   324.33 (+4.53%)
NASDAQ:MRAI

Marpai - MRAI Stock Forecast, Price & News

$0.94
-0.02 (-2.09%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.93
$0.99
50-Day Range
$0.85
$1.15
52-Week Range
$0.69
$5.03
Volume
10,515 shs
Average Volume
18,781 shs
Market Capitalization
$19.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

Marpai MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
166.3% Upside
$2.50 Price Target
Short Interest
Healthy
0.91% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$100,930 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Business Services Sector

178th out of 320 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

4th out of 8 stocks

MRAI stock logo

About Marpai (NASDAQ:MRAI) Stock

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.

Receive MRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter.

MRAI Stock News Headlines

Marpai Announces Virta as Diabetes Premium Health Partner
Marpai, Inc. (MRAI) Q3 2022 Earnings Call Transcript
MARPAI, INC. REPORTS THIRD QUARTER 2022 RESULTS
Marpai's Earnings Outlook
Marpai rallies after directors buy shares
MARPAI, INC. REPORTS SECOND QUARTER 2022 RESULTS
MARPAI, INC. REPORTS FIRST QUARTER 2022 RESULTS
See More Headlines
Receive MRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter.

MRAI Company Calendar

Last Earnings
11/09/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/29/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:MRAI
Fax
N/A
Employees
2,021
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.50
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+166.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-15,980,000.00
Net Margins
-104.66%
Pretax Margin
-104.66%

Debt

Sales & Book Value

Annual Sales
$14.23 million
Book Value
$1.48 per share

Miscellaneous

Free Float
12,270,000
Market Cap
$19.66 million
Optionable
Not Optionable
Beta
0.27

Key Executives

  • Mr. Edmundo GonzalezMr. Edmundo Gonzalez (Age 49)
    Co-Founder, CEO, Sec. & Director
    Comp: $287.81k
  • Mr. Yoram BibringMr. Yoram Bibring (Age 64)
    Chief Financial Officer
    Comp: $279.5k
  • Mr. Arthur Hoath IV (Age 52)
    Chief Revenue Officer
    Comp: $331.74k
  • Mr. Yaron I. Eitan (Age 66)
    Co-Founder & Chairman
  • Dr. Eli David (Age 40)
    Co-Founder, Chairman of the Advisory Board & Chief Science Advisor
  • Ms. Ronnie Brown (Age 68)
    Chief Operating Officer
  • Ms. Pamela Burns
    VP of Enterprise Sales
  • Mr. Lutz Finger (Age 51)
    Pres of Product & Devel.
  • Ms. Alice Roth (Age 60)
    Pres of Marpai Labs













MRAI Stock - Frequently Asked Questions

Should I buy or sell Marpai stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marpai in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MRAI shares.
View MRAI analyst ratings
or view top-rated stocks.

What is Marpai's stock price forecast for 2023?

1 Wall Street analysts have issued 12-month target prices for Marpai's shares. Their MRAI share price forecasts range from $2.50 to $2.50. On average, they predict the company's share price to reach $2.50 in the next year. This suggests a possible upside of 166.3% from the stock's current price.
View analysts price targets for MRAI
or view top-rated stocks among Wall Street analysts.

How have MRAI shares performed in 2022?

Marpai's stock was trading at $4.38 on January 1st, 2022. Since then, MRAI shares have decreased by 78.6% and is now trading at $0.9387.
View the best growth stocks for 2022 here
.

When is Marpai's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our MRAI earnings forecast
.

How were Marpai's earnings last quarter?

Marpai, Inc. (NASDAQ:MRAI) released its earnings results on Wednesday, November, 9th. The company reported ($0.28) earnings per share for the quarter. The business had revenue of $4.94 million for the quarter. Marpai had a negative net margin of 104.66% and a negative trailing twelve-month return on equity of 108.51%.

When did Marpai IPO?

(MRAI) raised $25 million in an IPO on Wednesday, October 27th 2021. The company issued 6,300,000 shares at $4.00 per share. ThinkEquity served as the underwriter for the IPO.

What is Marpai's stock symbol?

Marpai trades on the NASDAQ under the ticker symbol "MRAI."

Who are Marpai's major shareholders?

Marpai's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Jane Street Group LLC (0.12%). Insiders that own company stock include Damien Lamendola, Edmundo Gonzalez, Jane Cavalier, Ronnie Brown, Vincent Kane, Yaron Eitan and Yoram Bibring.
View institutional ownership trends
.

How do I buy shares of Marpai?

Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Marpai's stock price today?

One share of MRAI stock can currently be purchased for approximately $0.94.

How much money does Marpai make?

Marpai (NASDAQ:MRAI) has a market capitalization of $19.66 million and generates $14.23 million in revenue each year. The company earns $-15,980,000.00 in net income (profit) each year or ($1.24) on an earnings per share basis.

How many employees does Marpai have?

The company employs 2,021 workers across the globe.

How can I contact Marpai?

The official website for the company is www.marpaihealth.com. The company can be reached via phone at 646-303-3483 or via email at dave@redchip.com.

This page (NASDAQ:MRAI) was last updated on 12/9/2022 by MarketBeat.com Staff